More companies are starting to shine this earnings season with the Q4 EPS scorecard for the S&P 500 members that have reported results so far up roughly 6% from last year.

This week’s earnings lineup has featured several top-rated Zacks stocks that have added to this optimistic growth narrative and here are a few to consider.

Energy Transfer ET: Starting with Energy Transfer which currently boasts a Zacks Rank #1 (Strong Buy), the limited partnership with diversified energy assets posted Q4 earnings of $0.37 a share on Wednesday which beat the Zacks Consensus of $0.29 a share by 27%.

Image Source: Zacks Investment Research

Fourth quarter EPS also grew 8% from a year ago and earnings estimate revisions for fiscal 2024 and FY25 are up 5% and 9% over the last 30 days respectively. Notably, Energy Transfer’s Zacks Oil and Gas-Production Pipeline-MLB Industry is currently in the top 20% of over 250 Zacks industries.

Zacks Investment Research
Image Source: Zacks Investment Research

Blackline BLThe tech sector has largely contributed to the broader growth in this year’s Q4 earnings season with internet software player Blackline adding to this correspondence on Tuesday. Blackline sports a Zacks Rank #2 (Buy) and the Zacks Internet-Software Industry is in the top 30% at the moment.  

Providing cloud-based solutions for finance and accounting purposes Blackline’s Q4 earnings nearly doubled to $0.69 a share and came in 25% above estimates of $0.55 a share. Most intriguing, Blackline’s gross profit has kept soaring jumping 11% from the comparative quarter to $118.11 million with the chart below set to ascend higher.

Zacks Investment Research
Image Source: Zacks Investment Research

DaVita DVA: Dialysis services provider DaVita sports a Zacks Rank #2 (Buy) and continues to reconfirm its appealing growth potential among the medical sector. Furthermore, DaVita’s Zacks Medical-Outpatient and Home Healthcare Industry is in the top 28% of all Zacks industries.

Correlating with such, DaVita posted Q4 earnings of $1.87 per share on Tuesday surpassing estimates of $1.53 a share by 22%. More impressive, Q4 EPS soared 68% from $1.11 a share in the prior year quarter. Plus, DaVita has exceeded earnings expectations for five straight quarters posting a very impressive average earnings surprise of 35% in its last four quarterly reports.

Zacks Investment Research
Image Source: Zacks Investment Research

Takeaway

Investors are always looking for stocks of companies that illustrate business operations are stronger than anticipated. These top-rated Zacks stocks fit the bill after easily surpassing their Q4 earnings expectations and it would be no surprise if they drift higher in the coming weeks.

Zacks Names “Single Best Pick to Double”

From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.

It’s credited with a “watershed medical breakthrough” and is developing a bustling pipeline of other projects that could make a world of difference for patients suffering from diseases involving the liver, lungs, and blood. This is a timely investment that you can catch while it emerges from its bear market lows.

It could rival or surpass other recent Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year.

Free: See Our Top Stock And 4 Runners Up

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

DaVita Inc. (DVA) : Free Stock Analysis Report

Energy Transfer LP (ET) : Free Stock Analysis Report

BlackLine (BL) : Free Stock Analysis Report

To read this article on Zacks.com click here.

Zacks Investment Research

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.



Image and article originally from www.nasdaq.com. Read the original article here.

By Zacks